MX347677B - Formulacion farmaceutica entre jasmonatos y sus derivados y nanoportadores o microportadores. - Google Patents

Formulacion farmaceutica entre jasmonatos y sus derivados y nanoportadores o microportadores.

Info

Publication number
MX347677B
MX347677B MX2011000400A MX2011000400A MX347677B MX 347677 B MX347677 B MX 347677B MX 2011000400 A MX2011000400 A MX 2011000400A MX 2011000400 A MX2011000400 A MX 2011000400A MX 347677 B MX347677 B MX 347677B
Authority
MX
Mexico
Prior art keywords
jasmonates
pharmaceutical composition
compositions
polyamidoamine
carrier
Prior art date
Application number
MX2011000400A
Other languages
English (en)
Other versions
MX2011000400A (es
Inventor
E Fehr Pereira Lopes José
Original Assignee
E Fehr Pereira Lopes José
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E Fehr Pereira Lopes José filed Critical E Fehr Pereira Lopes José
Publication of MX2011000400A publication Critical patent/MX2011000400A/es
Publication of MX347677B publication Critical patent/MX347677B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a los composiciones farmacéuticas que comprenden un derivado del ácido jasmónico y un portador, preferentemente ciclodextrina o una poliamidoamina. Las composiciones pueden ser utilizadas para tratar el cáncer.
MX2011000400A 2008-07-15 2009-05-28 Formulacion farmaceutica entre jasmonatos y sus derivados y nanoportadores o microportadores. MX347677B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0804172-5A BRPI0804172A2 (pt) 2008-07-15 2008-07-15 compostos quìmicos formados a partir de nanoencapsulamentos e complexação de elementos
PCT/BR2009/000151 WO2010006392A2 (en) 2008-07-15 2009-05-28 Pharmaceutical formulation between jasmonates and it derivatives and nanocarries or microcarri es

Publications (2)

Publication Number Publication Date
MX2011000400A MX2011000400A (es) 2011-04-26
MX347677B true MX347677B (es) 2017-05-09

Family

ID=41550752

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011000400A MX347677B (es) 2008-07-15 2009-05-28 Formulacion farmaceutica entre jasmonatos y sus derivados y nanoportadores o microportadores.

Country Status (11)

Country Link
US (2) US20110305731A1 (es)
EP (1) EP2320879A4 (es)
JP (5) JP2011527989A (es)
KR (2) KR101751918B1 (es)
CN (1) CN102215832A (es)
AR (1) AR076732A1 (es)
BR (1) BRPI0804172A2 (es)
CA (1) CA2730876A1 (es)
MX (1) MX347677B (es)
RU (1) RU2011101961A (es)
WO (1) WO2010006392A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0804172A2 (pt) * 2008-07-15 2010-07-06 Pereira Lopes Jose Emilio Fehr compostos quìmicos formados a partir de nanoencapsulamentos e complexação de elementos
AU2012221877A1 (en) * 2011-02-25 2013-09-19 Nanocare Technologies, Inc. Pharmaceutical formulation comprising compounds of the jasmonate family
JP2014526519A (ja) * 2011-09-16 2014-10-06 ナノケア テクノロジーズ，インコーポレイティド ジャスモネート化合物の組成物および使用方法
WO2016109779A1 (en) 2014-12-31 2016-07-07 Nanocare Technologies, Inc. Jasmonate derivatives and compositions thereof
CN107551275B (zh) * 2017-09-12 2020-06-12 山西大学 一种磁性纳米药物载体的制备及其负载盐酸阿霉素的方法
CN114171111B (zh) * 2021-11-12 2024-06-28 中检科健(天津)检验检测有限责任公司 一种化学物质p-糖蛋白相互作用qsar筛选方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69020408T2 (de) * 1989-04-12 1996-01-04 Procter & Gamble Festes Verbraucherprodukt, welches feinteilige Cyclodextrin-Komplexe enthält.
CA2013485C (en) * 1990-03-06 1997-04-22 John Michael Gardlik Solid consumer product compositions containing small particle cyclodextrin complexes
JP3568325B2 (ja) * 1996-07-12 2004-09-22 株式会社ノエビア 抗アンドロゲン剤及び養毛剤並びに毛髪用化粧料
JP3596835B2 (ja) * 1996-08-13 2004-12-02 株式会社ノエビア 養毛剤
EP0988025A1 (en) * 1997-06-09 2000-03-29 The Procter & Gamble Company Perfumed compositions and methods for reducing body odors and excess moisture
US6790815B1 (en) * 1998-07-10 2004-09-14 Procter & Gamble Company Amine reaction compounds comprising one or more active ingredient
CA2439953A1 (en) * 2001-03-08 2002-09-19 Mark D. Bednarski Stabilized therapeutic and imaging agents
US6469061B1 (en) * 2001-04-04 2002-10-22 Ramot University Authority For Applied Research And Industrial Development Limited Jasmonate pharmaceutical composition for treatment of cancer
US20030224024A1 (en) * 2002-02-04 2003-12-04 Jean-Luc Leveque Compositions comprising cyclopentane derivatives and their use
KR100789343B1 (ko) * 2004-09-07 2007-12-28 주식회사 엘지생활건강 화장용 분체, 그의 제조방법 및 이를 함유하는 메이컵화장품 조성물
US7258878B2 (en) * 2004-12-20 2007-08-21 Kimberly-Clark Worldwide, Inc. Anti-microbial composition and methods of use thereof
ES2265291B1 (es) * 2005-07-22 2008-03-01 Universidad De Alcala Nuevos dendrimeros carbosilanos, su preparacion y sus usos.
WO2007103336A2 (en) * 2006-03-06 2007-09-13 The Board Of Trustees Operating Micro-encapsulation of volatile compounds into cyclodextrins
US20090185985A1 (en) * 2006-06-13 2009-07-23 Cargill, Incorporated Large-particle cyclodextrin inclusion complexes and methods of preparing same
JP2009542799A (ja) * 2006-07-10 2009-12-03 ラモト アット テル − アビブ ユニバーシティー リミテッド 組合せ癌治療方法
BRPI0604024A (pt) * 2006-09-01 2008-04-22 Beyond Lifescience Pesquisa De alimentos para a prevenção do cáncer e composições farmacêuticas à base do jasmonato
BRPI0804172A2 (pt) * 2008-07-15 2010-07-06 Pereira Lopes Jose Emilio Fehr compostos quìmicos formados a partir de nanoencapsulamentos e complexação de elementos

Also Published As

Publication number Publication date
US20110305731A1 (en) 2011-12-15
US20160354312A1 (en) 2016-12-08
WO2010006392A3 (en) 2010-03-18
JP2014237688A (ja) 2014-12-18
WO2010006392A2 (en) 2010-01-21
JP2016216496A (ja) 2016-12-22
AR076732A1 (es) 2011-07-06
KR101751918B1 (ko) 2017-06-30
EP2320879A4 (en) 2014-03-05
MX2011000400A (es) 2011-04-26
EP2320879A2 (en) 2011-05-18
KR20170076788A (ko) 2017-07-04
BRPI0804172A2 (pt) 2010-07-06
JP2011527989A (ja) 2011-11-10
KR20110031232A (ko) 2011-03-24
JP2018030868A (ja) 2018-03-01
RU2011101961A (ru) 2012-08-20
JP2019070008A (ja) 2019-05-09
CN102215832A (zh) 2011-10-12
CA2730876A1 (en) 2010-01-21

Similar Documents

Publication Publication Date Title
PH12017502300A1 (en) Pesticidal compositions and processes related thereto
MY153915A (en) Organic compounds
WO2009152356A3 (en) Compounds and compositions useful for the treatment of malaria
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
PH12013502192A1 (en) Antibodies against human angiopoietin 2
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
EA201001639A1 (ru) Композиции и способы их получения и применения
EP2321264A4 (en) DEACETYLASEINHIBITORS AND APPLICATIONS THEREOF
WO2009046841A8 (de) Piperidin- und piperazinderivate zur behandlung von tumoren
TN2011000279A1 (en) Novel pyrazole -4-n-alkoxycarboxamides as microbiocides
MX361467B (es) Compuestos de isoindolina para uso en el tratamiento de cancer.
MX2011005934A (es) Compuestos organicos.
CR20120202A (es) Métodos y composiciones para tratar cáncer
EP4374878A3 (en) Pharmaceutical composition
EA201170832A1 (ru) Пуриновые соединения
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MX2012002366A (es) Agonistas novedosos de receptores beta 3 andrenergicos derivados de pirrolidina.
MX2012004780A (es) Inhibidores de akt.
MX2010003365A (es) Derivados de tiazol para el tratamiento de cancer.
MY161473A (en) Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
MX347677B (es) Formulacion farmaceutica entre jasmonatos y sus derivados y nanoportadores o microportadores.
EP2131849A4 (en) COMPOSITIONS AND METHODS OF DISTRIBUTING AGENTS AGAINST CANCER
WO2010027424A3 (en) 9-substituted phenanthrene based tylophorine derivatives
AU2011279845A8 (en) Novel pyrrolidine derived beta 3 adrenergic receptor agonists

Legal Events

Date Code Title Description
FG Grant or registration